The State of "freeze-for-all" in Human ARTs

Overview

Journal J Assist Reprod Genet

Publisher Springer

Specialties Genetics
Reproductive Medicine

Date 2016 Sep 16

PMID 27629122

Citations 12

Authors

Natalia Basile

Juan A Garcia-Velasco

Affiliations

Soon will be listed here.

Abstract

The recent development of vitrification technologies and the good outcomes obtained in assisted reproduction technologies have supported new indications for freezing and segmentation of treatment. Beyond OHSS prevention and avoidance of embryo transfers in the setting of an adverse endocrinological profile or endometrial cavity, we have witnessed a trend to shift fresh embryo transfers to frozen embryo transfers in many programs. We critically review the available evidence and suggest that freeze-all is not "for all," but should be individualized.

Citing Articles

FSH/LH co-stimulation in Advanced Maternal Age (AMA) and hypo-responder patients - Arabian gulf delphi consensus group.

Awwad J, Peramo B, Elgeyoushi B, Melado L, Salame A, Chawla M Front Endocrinol (Lausanne). 2024; 15:1506332.

PMID: 39726844 PMC: 11669953. DOI: 10.3389/fendo.2024.1506332.

Frozen Blastocyst Embryo Transfer: Comparison of Protocols and Factors Influencing Outcome.

Eleftheriadou A, Francis A, Wilcox M, Jayaprakasan K J Clin Med. 2022; 11(3).

PMID: 35160185 PMC: 8836366. DOI: 10.3390/jcm11030737.

Use of a new set of key performance indicators for evaluating the performance of an fertilization laboratory in which blastocyst culture and the freeze-all strategy are the primary treatment in patients with fertilization.

Wang H, Hong P, Li H, Zhou W, Li T J Int Med Res. 2021; 49(9):3000605211044364.

PMID: 34551603 PMC: 8485302. DOI: 10.1177/03000605211044364.

Lawsuit frequency and claims basis over lost, damaged, and destroyed frozen embryos over a 10-year period.

Letterie G, Fox D F S Rep. 2021; 1(2):78-82.

PMID: 34223222 PMC: 8244326. DOI: 10.1016/j.xfre.2020.06.007.

Early Pregnancy Outcomes in Fresh Versus Deferred Embryo Transfer Cycles for Endometriosis-Associated Infertility: A Retrospective Cohort Study.

Tan J, Cerrillo M, Cruz M, Cecchino G, Garcia-Velasco J J Clin Med. 2021; 10(2).

PMID: 33477585 PMC: 7831308. DOI: 10.3390/jcm10020344.

References

Li Z, Wang Y, Ledger W, Edgar D, Sullivan E . Clinical outcomes following cryopreservation of blastocysts by vitrification or slow freezing: a population-based cohort study. Hum Reprod. 2014; 29(12):2794-801. DOI: 10.1093/humrep/deu246. View

Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L . Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assist Reprod Genet. 2010; 27(7):357-63. PMC: 2922708. DOI: 10.1007/s10815-010-9412-9. View

Munne S, Chen S, Fischer J, Colls P, Zheng X, Stevens J . Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertil Steril. 2005; 84(2):331-5. DOI: 10.1016/j.fertnstert.2005.02.027. View

Borini A, Bonu M, Coticchio G, Bianchi V, Cattoli M, Flamigni C . Pregnancies and births after oocyte cryopreservation. Fertil Steril. 2004; 82(3):601-5. DOI: 10.1016/j.fertnstert.2004.04.025. View

Chia C, Chan W, Quah E, Cheng L . Triploid pregnancy after ICSI of frozen testicular spermatozoa into cryopreserved human oocytes: case report. Hum Reprod. 2000; 15(9):1962-4. DOI: 10.1093/humrep/15.9.1962. View

Devroey P, Polyzos N, Blockeel C . An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011; 26(10):2593-7. DOI: 10.1093/humrep/der251. View

Stehlik E, Stehlik J, Katayama K, Kuwayama M, Jambor V, Brohammer R . Vitrification demonstrates significant improvement versus slow freezing of human blastocysts. Reprod Biomed Online. 2005; 11(1):53-7. DOI: 10.1016/s1472-6483(10)61298-9. View

Olivennes F, Frydman R . Friendly IVF: the way of the future?. Hum Reprod. 1998; 13(5):1121-4. DOI: 10.1093/humrep/13.5.1121. View

Nachtigall R, Mac Dougall K, Lee M, Harrington J, Becker G . What do patients want? Expectations and perceptions of IVF clinic information and support regarding frozen embryo disposition. Fertil Steril. 2010; 94(6):2069-72. PMC: 2965265. DOI: 10.1016/j.fertnstert.2010.02.023. View

10.

Herrero L, Pareja S, Aragones M, Cobo A, Bronet F, Garcia-Velasco J . Oocyte versus embryo vitrification for delayed embryo transfer: an observational study. Reprod Biomed Online. 2014; 29(5):567-72. DOI: 10.1016/j.rbmo.2014.07.016. View

11.

Belva F, Bonduelle M, Roelants M, Verheyen G, Van Landuyt L . Neonatal health including congenital malformation risk of 1072 children born after vitrified embryo transfer. Hum Reprod. 2016; 31(7):1610-20. DOI: 10.1093/humrep/dew103. View

12.

Wildt L, Diedrich K, Van der Ven H, Al Hasani S, Hubner H, Klasen R . Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Hum Reprod. 1986; 1(1):15-9. DOI: 10.1093/oxfordjournals.humrep.a136334. View

13.

Atkinson P, Koch J, Ledger W . GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates. Aust N Z J Obstet Gynaecol. 2014; 54(6):581-5. DOI: 10.1111/ajo.12277. View

14.

Bloise E, Feuer S, Rinaudo P . Comparative intrauterine development and placental function of ART concepti: implications for human reproductive medicine and animal breeding. Hum Reprod Update. 2014; 20(6):822-39. PMC: 4196686. DOI: 10.1093/humupd/dmu032. View

15.

Herrero L, Pareja S, Losada C, Cobo A, Pellicer A, Garcia-Velasco J . Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril. 2010; 95(3):1137-40. DOI: 10.1016/j.fertnstert.2010.09.040. View

16.

Lode H, Torres A, Cockle A . What drives our choices? Evidence, guidelines or habit?. Int J Antimicrob Agents. 2007; 29 Suppl 1:S17-22. DOI: 10.1016/S0924-8579(07)70006-7. View

17.

Cobo A, Garrido N, Crespo J, Jose R, Pellicer A . Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online. 2012; 24(4):424-32. DOI: 10.1016/j.rbmo.2011.12.012. View

18.

Gook D, Edgar D . Human oocyte cryopreservation. Hum Reprod Update. 2007; 13(6):591-605. DOI: 10.1093/humupd/dmm028. View

19.

Stanger J, Yovich J . Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol. 1985; 92(4):385-93. DOI: 10.1111/j.1471-0528.1985.tb01113.x. View

20.

Youssef M, van der Veen F, Al-Inany H, Mochtar M, Griesinger G, Mohesen M . Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014; (10):CD008046. PMC: 10767297. DOI: 10.1002/14651858.CD008046.pub4. View